Compare two stocks side-by-side:

AbbVie Inc. ABBV | NYSE

$175.58 $4.06 | 2.37%
Market Cap: $310.27 B
PE Ratio: 61.39
52-Week Range: $153.09 - $207.32
10-year Total Return: +292.9%
Dividend Yield (FWD): 3.74%

Eli Lilly and Company LLY | NYSE

$767.76 $10.22 | 1.35%
Market Cap: $728.85 B
PE Ratio: 83
52-Week Range: $567.42 - $972.53
10-year Total Return: +1,196.0%
Dividend Yield (FWD): 0.78%

10-year Total Returns with DRIP & Price Chart for ABBV and LLY

1Y 2Y 5Y 10Y All
DRIPCalc.com
ABBV vs LLY Returns

10-year Performance: Total Return (with DRIP), Diviendeds & Portfolio Value:

ABBV LLY
Initial Balance $10,000 $10,000
Initial Price $66.97 $71.42
Initial Shares 149.32 140.02
 
Total Dividends $8,063 $4,936
Last Dividend $1.55 $1.3
Estimated Divs $347 / quarter $219 / quarter
Yield-on-Cost 9.26% 7.28%
End Shares 223.79 (+74.47) 168.8 (+28.78)
Last Shares Price $175.58 $767.76
Total End Value $39,293 $129,599
Total Return +292.9% +1,196.0%
Comparison start date: Dec 21, 2014

Dividend Payments & Dividend Yield Curve

Dividend Payments & Yield - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV Dividend CAGR:1Y: 5.81%2Y: 5.27%5Y: 6.81%10Y: 12.84%
Dividend Payments & Yield - LLY
14-Day FREE Trial Get Full Access Now!
LLY Dividend CAGR:1Y: 15.38%2Y: 15.21%5Y: 15.18%10Y: 11.61%

DRIPCalc PRO - Compare is a dividend stocks research & comparison tool, where you can see side-by-side and visually compare:

Dividend payments & dividend yield curve, earnigns, cash, debt and differnt ratios for 1000s of stocks.

In demo-mode, you can see and compare all reports and charts for AAPL and MSFT stocks. Other stocks are availabe for members of DRIPCalc PRO.

When you sign up for DRIPCalc PRO for just $15/mo and 2 weeks Free Trial with full access, you will be able to compare and research any stock or ETF in our vast database!

Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Dividend Safety: Payout & Dividend to Free Cash Flow Ratios

Dividend Payout Ratio - ABBV
14-Day FREE Trial Get Full Access Now!
Dividend Payout Ratio - LLY
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow (FCF) Ratio - ABBV
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow (FCF) Ratio - LLY
14-Day FREE Trial Get Full Access Now!

Price charts for ABBV and LLY.

Share Price - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV Price CAGR:1Y: 15.75%2Y: 4.57%5Y: 14.48%10Y: 10.00%
Share Price - LLY
14-Day FREE Trial Get Full Access Now!
LLY Price CAGR:1Y: 34.65%2Y: 46.11%5Y: 42.12%10Y: 26.63%

Earnings, Revenue, Net Income, Dividends, Cash & Debt, Shares Outstaning, and other charts:

EPS vs PE Ratio - ABBV
14-Day FREE Trial Get Full Access Now!
EPS vs PE Ratio - LLY
14-Day FREE Trial Get Full Access Now!
FCF vs FCF/Share - ABBV
14-Day FREE Trial Get Full Access Now!
FCF vs FCF/Share - LLY
14-Day FREE Trial Get Full Access Now!
EPS vs FCF per Share - ABBV
14-Day FREE Trial Get Full Access Now!
EPS vs FCF per Share - LLY
14-Day FREE Trial Get Full Access Now!
FCF vs Stock Based Comp - ABBV
14-Day FREE Trial Get Full Access Now!
FCF vs Stock Based Comp - LLY
14-Day FREE Trial Get Full Access Now!
Revenue vs Net Income - ABBV
14-Day FREE Trial Get Full Access Now!
Revenue vs Net Income - LLY
14-Day FREE Trial Get Full Access Now!
Cash & Debt - ABBV
14-Day FREE Trial Get Full Access Now!
Cash & Debt - LLY
14-Day FREE Trial Get Full Access Now!
Revenue - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV Revenue CAGR:1Y: 3.83%2Y: -1.20%5Y: 11.27%10Y: 11.16%
Revenue - LLY
14-Day FREE Trial Get Full Access Now!
LLY Revenue CAGR:1Y: 20.43%2Y: 28.37%5Y: 15.87%10Y: 8.90%
Earnings Per Share (EPS) - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV EPS CAGR:1Y: -12.00%2Y: -37.04%5Y: -6.93%10Y: 11.00%
Earnings Per Share (EPS) - LLY
14-Day FREE Trial Get Full Access Now!
LLY EPS CAGR:1Y: 1,777.12%2Y: -18.48%5Y: -4.82%10Y: 8.57%
Net Income - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV Net Income CAGR:1Y: -12.20%2Y: -37.13%5Y: -3.69%10Y: 11.92%
Net Income - LLY
14-Day FREE Trial Get Full Access Now!
LLY Net Income CAGR:1Y: 1,790.42%2Y: -18.24%5Y: -5.00%10Y: 6.84%
EBITDA - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV EBITDA CAGR:1Y: 102.01%2Y: -14.88%5Y: 9.60%10Y: 13.41%
EBITDA - LLY
14-Day FREE Trial Get Full Access Now!
LLY EBITDA CAGR:1Y: -64.88%2Y: -3.26%5Y: 7.22%10Y: 10.55%
Free Cash Flow - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV Free Cash Flow CAGR:1Y: -29.33%2Y: -16.33%5Y: 3.38%10Y: 12.46%
Free Cash Flow - LLY
14-Day FREE Trial Get Full Access Now!
LLY Free Cash Flow CAGR:1Y: -74.67%2Y: N/A5Y: N/A10Y: N/A
Free Cash Flow / Share - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV Free Cash Flow / Share CAGR:1Y: -29.41%2Y: -16.28%5Y: -0.22%10Y: 11.30%
Free Cash Flow / Share - LLY
14-Day FREE Trial Get Full Access Now!
LLY Free Cash Flow / Share CAGR:1Y: -74.70%2Y: N/A5Y: N/A10Y: N/A
Stock-Based Comp - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV Stock-Based Comp CAGR:1Y: 39.23%2Y: 19.85%5Y: 19.27%10Y: 15.19%
Stock-Based Comp - LLY
14-Day FREE Trial Get Full Access Now!
LLY Stock-Based Comp CAGR:1Y: -38.22%2Y: 25.11%5Y: 12.02%10Y: 13.22%
Expenses - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV Expenses CAGR:1Y: 22.50%2Y: 15.25%5Y: -10.30%10Y: -0.83%
Expenses - LLY
14-Day FREE Trial Get Full Access Now!
LLY Expenses CAGR:1Y: 9.62%2Y: 49.34%5Y: 14.65%10Y: 5.71%
Dividends - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV Dividend CAGR:1Y: 5.81%2Y: 5.27%5Y: 6.81%10Y: 12.84%
Dividends - LLY
14-Day FREE Trial Get Full Access Now!
LLY Dividend CAGR:1Y: 15.38%2Y: 15.21%5Y: 15.18%10Y: 11.61%
Shares Outstanding - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV Shares Outstanding CAGR:1Y: 0.06%2Y: -0.11%5Y: 3.62%10Y: 0.96%
Shares Outstanding - LLY
14-Day FREE Trial Get Full Access Now!
LLY Shares Outstanding CAGR:1Y: 0.58%2Y: 0.07%5Y: -0.30%10Y: -1.70%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

REVENUE: Actual + Estimates - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV Actual Revenue CAGR:1Y: 3.83%2Y: -1.20%5Y: 11.27%10Y: 11.16%
REVENUE: Actual + Estimates - LLY
14-Day FREE Trial Get Full Access Now!
LLY Actual Revenue CAGR:1Y: 20.43%2Y: 28.37%5Y: 15.87%10Y: 8.90%
EPS: Actual + Estimates - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV Actual EPS CAGR:1Y: -12.00%2Y: -37.04%5Y: -6.93%10Y: 11.00%
EPS: Actual + Estimates - LLY
14-Day FREE Trial Get Full Access Now!
LLY Actual EPS CAGR:1Y: 1,777.12%2Y: -18.48%5Y: -4.82%10Y: 8.57%
NET INCOME: Actual + Estimates - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV Actual Net Income CAGR:1Y: -12.20%2Y: -37.13%5Y: -3.69%10Y: 11.92%
NET INCOME: Actual + Estimates - LLY
14-Day FREE Trial Get Full Access Now!
LLY Actual Net Income CAGR:1Y: 1,790.42%2Y: -18.24%5Y: -5.00%10Y: 6.84%
EBITDA: Actual + Estimates - ABBV
14-Day FREE Trial Get Full Access Now!
ABBV Actual EBITDA CAGR:1Y: 102.01%2Y: -14.88%5Y: 9.60%10Y: 13.41%
EBITDA: Actual + Estimates - LLY
14-Day FREE Trial Get Full Access Now!
LLY Actual EBITDA CAGR:1Y: -64.88%2Y: -3.26%5Y: 7.22%10Y: 10.55%

Ratios, Profit Margins & Return on Capital:

Net Profit Margin - ABBV
14-Day FREE Trial Get Full Access Now!
Net Profit Margin CAGR:1Y: -15.43%2Y: -36.35%5Y: -13.44%10Y: 0.69%
Net Profit Margin - LLY
14-Day FREE Trial Get Full Access Now!
Net Profit Margin CAGR:1Y: 1,513.33%2Y: -36.32%5Y: -18.02%10Y: -1.90%
Gross Profit Margin - ABBV
14-Day FREE Trial Get Full Access Now!
Gross Profit Margin CAGR:1Y: 32.62%2Y: 3.55%5Y: -1.74%10Y: -0.98%
Gross Profit Margin - LLY
14-Day FREE Trial Get Full Access Now!
Gross Profit Margin CAGR:1Y: 0.75%2Y: 2.41%5Y: 0.62%10Y: 0.91%
Price to Earnings - ABBV
14-Day FREE Trial Get Full Access Now!
Price to Earnings - LLY
14-Day FREE Trial Get Full Access Now!
Price To Sales Ratio - ABBV
14-Day FREE Trial Get Full Access Now!
Price To Sales Ratio - LLY
14-Day FREE Trial Get Full Access Now!
Return on Capital Employed - ABBV
14-Day FREE Trial Get Full Access Now!
Return on Capital Employed - LLY
14-Day FREE Trial Get Full Access Now!
Return on Invested Capital - ABBV
14-Day FREE Trial Get Full Access Now!
Return on Invested Capital - LLY
14-Day FREE Trial Get Full Access Now!

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Values & Dividends for ABBV & LLY

Based on past 10 years performance, ABBV had share price CAGR of +10.12%, and dividend CAGR of +12.84%.

During same period LLY had share price CAGR of +26.81%, and dividend CAGR of +11.61%.

Using these CAGR metrics, we can estimate, that your initial $10,000 investment from 10 years ago, with dividends being reinvested (DRIP) should grow and collect dividends as follows:

ABBVLLY
Start Value$10,000$10,000
Start Share Price$175.58$767.76
Start Shares56.9513.02
  
After 10 years:ABBVLLY
Final Share Count84.3913.57
Dividends Payment$5.19$3.90
Annual Dividends$1,751$212
Share Price$418.03$6,508.64
Total Dividends$8,107$1,199
Final Value$35,276$88,298

Estimated Future Returns - ABBV
Estimated Future Returns - LLY

Estimate Dividend Snowball and total future returns for ABBV and LLY with our dividend (DRIP) calculator.

Above numbers are merely projections based on Dividend and Price CAGR for each stock, and should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these metrics.